Recent research has highlighted the importance of glucagon ... of GLP-1 receptor (GLP-1R) antagonists. By conjugating the antagonist exendin(9-39) to a cell-penetrating peptide, they enhanced ...

Objective. Glucagon-like peptide-1 (GLP-1) has many effects on glucose homeostasis, and GLP-1 receptors are broadly represented in many tissues including the brain. Recent research in rodents ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.

A RECENT population-based analysis has highlighted potential behavioural side effects associated with Glucagon-like peptide 1 ...

With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...

HealthDay News — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term, according to a study published online January ...

The following is a summary of “Treatment of Hypothalamic Obesity With GLP-1 Analogs,” published in the November 2024 issue of Endocrinology by Dimitri and Roth. Damage to hypothalamic nuclei or ...

Glucagon-Like Peptide-2 (GLP-2) is a hormone produced ... Studies indicate that GLP-2 binds to specific receptors in the gastrointestinal tract, influencing the movement of food through the ...

We favor macromolecules such as endogenous peptide and protein hormones ... binding face that is promiscuous for the GLP-1, glucagon, and GIP receptors. These GLP-1-glucagon-GIP triagonists ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...